“
“Aquaporin (AQP) is

suggested to be regulated by leptin through the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway. AQP7 and AQP9 are membrane proteins with water and glycerol channels, the latter of which is essential for triglyceride synthesis. We conjectured that the expression of AQP7 and AQP9 would be altered in the skeletal myofibers in obese leptin deficient ob/ob mice as compared with that of wild mice. RNA and protein levels were studied in the quadriceps femoris muscles of ob/ob and wild mice. Real time quantitative RT-PCR analysis showed that mouse AQP7 mRNA levels in skeletal see more muscles were significantly higher in ob/ob mice than in wild mice (P smaller than 0.01), whereas mouse AQP9 mRNA level was not different between the two groups (P bigger than 0.05). Histologically the type 1 myofibers of ob/ob mice contained numerous lipid droplets

in oil red O stain samples. Immunohistochemical staining of ob/ob mouse muscles revealed enhanced expression of AQP7 at myofiber surface membranes, while AQP9 expression appeared to be similar to that of wild mice. The findings suggest that the upregulated expression of AQP7 in ob/ob mouse compound screening assay muscles facilitates the secretion of glycerol from myocytes.”
“Goals: Cell population data (CPD) are new morphologic parameters including volume, conductivity, and

five light scattering characteristics used for leukocyte classification by an automated hematology analyzer, the UniCel DxH 800. We developed a discriminating CPD model to predict the leukemia lineage during routine complete blood cell count (CBC). Procedures: We analyzed the CPD of 405 blood samples containing more than 10% blasts that were randomly divided into test and validation sets. With the test set, we produced a model for categorizing acute lymhoblastic leukemia Ricolinostat cell line (ALL) or acute promyelocytic leukemia (APL), using ranges of the CPD and regarding the remainder as non-APL acute myeloid leukemia. We verified these models against the validation set. Results: In the test set, we formulated a 21-parameter model which identified 43 of 47 ALL cases (91.5% sensitivity) and ruled out 151 of 156 other leukemia cases (96.8% specificity), and a 13-parameter model which distinguished all 10 APL cases (100% sensitivity) and excluded 193 other leukemia cases (100% specificity). In the validation set, the ALL model showed 85.1% sensitivity and 94.2% specificity, and the APL model 100% sensitivity and 100% specificity. Conclusions: This study demonstrated a new solution for predicting blast lineage using the CPD on a CBC and leukocyte differential.